/Investor DB

Salica Investments — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Theremiatheremia.healthinSeed · Feb 2025 · $3M

Theremia develops statistical methods for analyzing clinical trial outcomes, including a Nearest Neighbor Pairing approach to improve Win Ratio estimation of individual causal treatment effects in heterogeneous patient populations.

AI & Machine LearningBiotechDigital HealthParis, FR

Iris Maréchal(CEO)inChloé Geoffroy(Cofounder)in

Co-investorsAgoranovEntrepreneur FirstBetter AngleBpifranceEurazeo

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.